文献速递乳房整形与再造

乳房假体相关间变性大细胞淋巴瘤与毛面假体:手术风险管理证据的系统综述

BIA-ALCL and Textured Breast Implants: A Systematic Review of Evidence Supporting Surgical Risk Management Strategies.
PubMed 文献 · Plast Reconstr Surg · 2021-01-01

该研究系统综述了毛面乳房假体患者中BIA-ALCL手术风险降低技术及沟通/知情同意实践。共纳入276篇文章,但无一篇符合纳入标准提供手术措施降低BIA-ALCL风险的证据。结论认为风险管理证据缺乏,更换毛面假体为光面假体降低风险的观念尚无证据支持。

要点

  • 无证据支持手术措施可降低BIA-ALCL风险。
  • 尚无证据表明将毛面假体更换为光面假体可降低风险。
  • 风险估计的变异性致许多患者选择更换假体。

核心结论

  • BIA-ALCL风险管理是需进一步研究的演进领域。
  • 目前无证据支持更换毛面假体为光面假体可降低BIA-ALCL风险。

研究设计与样本

  • 系统综述,检索PubMed、Embase和Scopus数据库。
  • 共识别571篇文章,去重后276篇纳入最终综述。

主要发现

  • 无文章符合纳入标准证明手术措施可降低BIA-ALCL风险。
  • 数据显示BIA-ALCL风险降低证据显著缺乏。

关键数值与推荐

  • FDA目前不推荐无症状患者移除毛面假体。
  • 风险估计的变异性导致许多患者选择更换假体以降低风险。

临床怎么用

  • 应利用此信息辅助毛面乳房假体管理讨论中的知情同意过程。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a significant public health concern for women with breast implants. The increase in incidence rates underscores the need for improved methods for risk reduction and risk management. The purpose of this study was to perform a systematic review to assess surgical risk reduction techniques and analyze communication/informed consent practices in patients with textured implants. METHODS: A systematic review of the literature was conducted in PubMed (legacy), Embase (Embase.com), and Scopus with four search strategies including key terms centered around breast reconstruction and BIA-ALCL. RESULTS: A total of 571 articles were identified, of which 276 were included in the final review after duplicates were removed. After review, no articles were determined to fit the inclusion criteria of demonstrating data-driven evidence of BIA-ALCL risk reduction through surgical measures, demonstrating a significant lack of data on risk reduction for BIA-ALCL. CONCLUSIONS: Risk management for BIA-ALCL is an evolving area requiring additional investigation. Although removal of textured devices in asymptomatic patients is not currently recommended by the Food and Drug Administration, variability in estimates of risk has led many patients to electively replace these implants in an effort to decrease their risk of developing BIA-ALCL. To date, however, there is no evidence supporting the concept that replacing textured implants with smooth implants reduces risk for this disease. This information should be used to aid in the informed consent process for patients presenting to discuss management of textured breast implants.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Nelson JA, McCarthy C, Dabic S, et al. BIA-ALCL and Textured Breast Implants: A Systematic Review of Evidence Supporting Surgical Risk Management Strategies. Plast Reconstr Surg. 2021. PMID: 33890875. doi:10.1097/PRS.0000000000008040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。